Healthcare - Biotechnology - NASDAQ - US
$ 2.4
-8.05 %
$ 144 M
Market Cap
-2.16
P/E
INCOME STATEMENT
0
REVENUE
-61.1 M
OPERATING INCOME
-52.4 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Acumen Pharmaceuticals, Inc.
| Revenue | 0 |
| Cost Of Revenue | 42.3 M |
| Gross Profit | -42.3 M |
| Operating Expenses | 61.1 M |
| Operating Income | -61.1 M |
| Other Expenses | -8.77 M |
| Net Income | -52.4 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 0 | 0 | 0 | 1.4 | 1.7 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 42.3 | 0.2 | 4 K | 8 K | 8.58 K |
| Gross Profit | (42.3) | (0.2) | 4 K | 1.4 | 1.7 |
| OPERATING INCOME | |||||
| Operating Expenses | 61.1 | 45.2 | 19.6 | 9.3 | 9.5 |
| Selling, General and Administrative Expenses | 18.8 | 12.9 | 7.3 | 1.4 | 0.9 |
| Research and Development Expenses | 42.3 | 32.4 | 12.3 | 8.0 | 8.6 |
| Operating Income | (61.1) | (45.2) | 61.6 | (7.9) | (7.8) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | (0.6) | (2.4) | 0 | 0 | 0 |
| Total Other Income | 8.8 | 2.4 | (81.0) | 0.6 | (0.1) |
| Pre-Tax Income | (52.4) | (42.9) | (100.6) | (7.3) | (7.9) |
| NET INCOME | |||||
| Tax Provision | 0 | (2.4) | 81.1 | 1 K | 45 K |
| Net Income | (52.4) | (40.5) | (181.7) | (7.3) | (7.9) |
| EPS | 1.08 | 1 | 4.49 | 0.18 | 0.2 |